MFDS — authorised 17 May 1962
- Marketing authorisation holder: PAR STERILE PRODUCTS
- Status: likely_approved
🇰🇷 Coly-Mycin S in South Korea
MFDS authorised Coly-Mycin S on 17 May 1962
Marketing authorisation
Coly-Mycin S in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Coly-Mycin S approved in South Korea?
Yes. MFDS authorised it on 17 May 1962.
Who is the marketing authorisation holder for Coly-Mycin S in South Korea?
PAR STERILE PRODUCTS holds the South Korean marketing authorisation.